John Overdeck’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-500,000
Closed -$5.4M 3343
2023
Q3
$5.4M Hold
500,000
0.01% 864
2023
Q2
$5.33M Hold
500,000
0.01% 900
2023
Q1
$5.25M Hold
500,000
0.02% 879
2022
Q4
$5.13M Hold
500,000
0.02% 842
2022
Q3
$5M Buy
+500,000
New +$5.01M 0.02% 756

Other funds holding RENE

John Overdeck's RENE Position: Q4 2023 in Review

John Overdeck sold out of Cartesian Growth Corp II (RENE) in Q4 2023, closing a stake of 500,000 shares — an estimated $5.4M sold.

John Overdeck first reported a position in RENE in Q3 2022 and held it in 5 quarters. The position peaked at $5.4M in Q3 2023. 34 funds tracked by Wall St. Rank hold RENE as of Q4 2023.

  • John Overdeck reported no remaining Cartesian Growth Corp II position as of Q4 2023 after selling out during the quarter.
  • John Overdeck sold 500,000 Cartesian Growth Corp II shares in Q4 2023, an estimated $5.4M.
  • John Overdeck first reported a position in Cartesian Growth Corp II in Q3 2022 and held it in 5 quarters.
  • John Overdeck's Cartesian Growth Corp II position peaked at $5.4M in Q3 2023.
  • 34 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q4 2023.

Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.